- $4.5 BnWorld market, 2023
- $13.2 BnProjected, 2033
- 11.4%Growth a year (CAGR)
- 98Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$1.9 Bn
9.4% a year · 42% of the world -
2
China
$362 Mn
12.9% a year · 8% of the world -
3
Canada
$360 Mn
11.4% a year · 8% of the world -
4
Japan
$280 Mn
11.9% a year · 6.2% of the world -
5
Germany
$165 Mn
9.6% a year · 3.7% of the world -
6
France
$124 Mn
10.4% a year · 2.7% of the world -
7
UK
$117 Mn
9.4% a year · 2.6% of the world -
8
Brazil
$113 Mn
12.4% a year · 2.5% of the world -
9
Italy
$108 Mn
10.9% a year · 2.4% of the world -
10
Ecuador
$90 Mn
12% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Medical Billing by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $4.5 Bn | $13.2 Bn | 11.4% | – | 98 | Report on Medical Billing in Global |
| North America | $2.3 Bn | $6.1 Bn | 10.4% | 50% | 47 | Report on Medical Billing in North America |
| APAC | $945 Mn | $3.1 Bn | 12.7% | 21% | 19 | Report on Medical Billing in APAC |
| Europe | $855 Mn | $2.2 Bn | 10.1% | 19% | 13 | Report on Medical Billing in Europe |
| Latin America | $203 Mn | $652 Mn | 12.4% | 4.5% | 3 | Report on Medical Billing in Latin America |
| Middle East | $180 Mn | $579 Mn | 12.4% | 4% | 0 | Report on Medical Billing in Middle East |
| Africa | $68 Mn | $227 Mn | 12.9% | 1.5% | 1 | Report on Medical Billing in Africa |
| US |
$1.9 Bn | $4.6 Bn | 9.4% | 42% | 40 | Report on Medical Billing in US |
| China |
$362 Mn | $1.2 Bn | 12.9% | 8% | 12 | Report on Medical Billing in China |
| Canada |
$360 Mn | $1.1 Bn | 11.4% | 8% | 9 | Report on Medical Billing in Canada |
| Japan |
$280 Mn | $861 Mn | 11.9% | 6.2% | 1 | Report on Medical Billing in Japan |
| Germany |
$165 Mn | $412 Mn | 9.6% | 3.7% | 8 | Report on Medical Billing in Germany |
| France |
$124 Mn | $333 Mn | 10.4% | 2.7% | 1 | Report on Medical Billing in France |
| UK |
$117 Mn | $287 Mn | 9.4% | 2.6% | 2 | Report on Medical Billing in UK |
| Brazil |
$113 Mn | $362 Mn | 12.4% | 2.5% | 3 | Report on Medical Billing in Brazil |
| Italy |
$108 Mn | $304 Mn | 10.9% | 2.4% | 1 | Report on Medical Billing in Italy |
| Ecuador |
$90 Mn | $280 Mn | 12% | 2% | 0 | Report on Medical Billing in Ecuador |
 Spain |
$87 Mn | $234 Mn | 10.4% | 1.9% | 5 | Report on Medical Billing in Spain |
 India |
$82 Mn | $314 Mn | 14.4% | 1.8% | 1 | Report on Medical Billing in India |
 Saudi Arabia |
$77 Mn | $257 Mn | 12.9% | 1.7% | 0 | Report on Medical Billing in Saudi Arabia |
 Mexico |
$68 Mn | $203 Mn | 11.7% | 1.5% | 1 | Report on Medical Billing in Mexico |
 Australia |
$54 Mn | $182 Mn | 12.9% | 1.2% | 0 | Report on Medical Billing in Australia |
 South Africa |
$29 Mn | $96 Mn | 12.6% | 0.6% | 0 | Report on Medical Billing in South Africa |
 UAE |
$23 Mn | $72 Mn | 12.4% | 0.5% | 0 | Report on Medical Billing in UAE |
 Egypt |
$13 Mn | $42 Mn | 12.9% | 0.3% | 1 | Report on Medical Billing in Egypt |
 Philippines |
$10 Mn | $31 Mn | 11.9% | 0.2% | 0 | Report on Medical Billing in Philippines |
 Hong Kong |
$7 Mn | $23 Mn | 12.4% | 0.2% | 0 | Report on Medical Billing in Hong Kong |
 Malaysia |
$7 Mn | $22 Mn | 11.6% | 0.2% | 0 | Report on Medical Billing in Malaysia |
 Singapore |
$5 Mn | $17 Mn | 12% | 0.1% | 5 | Report on Medical Billing in Singapore |
 Thailand |
$5 Mn | $16 Mn | 11.7% | 0.1% | 0 | Report on Medical Billing in Thailand |
 Kenya |
$3 Mn | $10 Mn | 12.5% | 0.1% | 0 | Report on Medical Billing in Kenya |
 New Zealand |
– | – | – | – | 0 | Report on Medical Billing in New Zealand |
 Russia |
– | – | – | – | 0 | Report on Medical Billing in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 3,615 papers since 2021
- Use of and Revenue From the G2211 Longitudinal Care Code Among Primary Care Clinicians and Practices. JAMA internal medicine, 2026
- Financial navigation in gynecologic oncology: a qualitative study. Gynecologic oncology reports, 2026
- Development and impact of a quality improvement intervention to increase lung cancer screening in rural Appalachia. Translational lung cancer research, 2026
- Trends in Dermatopathology Billing Costs for Melanocytic Lesions: A 10-Year Retrospective Analysis. The American Journal of dermatopathology, 2026
- Beyond Billing Codes: An Agentic Large Language Model Pipeline for Extracting Glaucoma Procedural Data from Free-Text Clinical Notes. medRxiv : the preprint server for health sciences, 2026
Compare Medical Billing side by side
Key companies in Medical Billing
R1 RCM Inc.
Allscripts Healthcare Solutions Inc.
Cerner Corporation
eClinicalWorks LLC
Experian Information Solutions Inc.
GE Healthcare
Kareo, Inc.
Genpact
McKesson Corporation
Quest Diagnostics
Allscripts Healthcare Solutions Inc.
Cerner Corporation
eClinicalWorks LLC
Experian Information Solutions Inc.
GE Healthcare
Kareo, Inc.
Genpact
McKesson Corporation
Quest Diagnostics
Quick answers
How big is the Medical Billing market?
The world Medical Billing market was worth about $4.5 Bn in 2023 and is projected to reach $13.2 Bn by 2033, growing 11.4% a year (CAGR).
Which country has the largest Medical Billing market?
The US is the largest of the 24 countries we cover, at $1.9 Bn in 2023. India grows fastest, at 14.4% a year.
How many clinical trials are running in Medical Billing?
ClinicalTrials.gov lists 98 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Medical Billing?
PubMed lists about 3,615 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.